Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic disease (COVID-19) that has spread globally causing more than 30,000 deaths. Despite the immense and ongoing global effort, no efficacious drugs to fight this plague have been identified and patients admitted to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Carboni, Elena, Carta, Anna R., Carboni, Ezio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175844/
https://www.ncbi.nlm.nih.gov/pubmed/32344313
http://dx.doi.org/10.1016/j.mehy.2020.109776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175844/
https://www.ncbi.nlm.nih.gov/pubmed/32344313
http://dx.doi.org/10.1016/j.mehy.2020.109776

Ejemplares similares